# Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency

> **NCT00446485** · PHASE4 · COMPLETED · sponsor: **Milsing d.o.o.** · enrollment: 90 (actual)

## Conditions studied

- Mild Cognitive Impairment
- Cerebrovascular Insufficiency

## Interventions

- **DRUG:** Ginkgo biloba standardized extract 24/6
- **DRUG:** Ginkgo Biloba standardized extract 24/6
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00446485
- **Lead sponsor:** Milsing d.o.o.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2015-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00446485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00446485, "Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00446485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*